AstraZeneca Plc is spinning off a company to develop drugs for immune disorders with as much as $250 million from a group of investors.
from Bloomberg http://ift.tt/2t9g2zF
Subscribe to:
Post Comments (Atom)
The wildfires have a Hollywood producer wondering: Should I even stay in LA?
Universal Studios Hollywood. Andia/Universal Images Group via Getty Images Los Angeles' fires threaten to hamper the entertainment ...
-
Before investing your own money into a small business idea, test it out with your target audience. Georgijevic/Getty Images Having a bu...
-
Omnicom CEO John Wren. Emmanuel Dunand/AFP via Getty Images Ad industry insiders say the Omnicom takeover of Interpublic Group could ki...
-
Krisanapong Detraphiphat/Getty Images; Jenny Change-Rodriguez/BI Illustration Goldman Sachs forecasts muted S&P 500 gains, with a ...
No comments:
Post a Comment